Suppr超能文献

当前对心血管疾病中piRNA的认识。

Current Understanding of piRNA in Cardiovascular Diseases.

作者信息

Cheang Iokfai, Zhu Qingqing, Liao Shengen, Li Xinli

机构信息

First Affiliated Hospital, Nanjing Medical University, Nanjing, China.

出版信息

Front Mol Med. 2022 Jan 12;1:791931. doi: 10.3389/fmmed.2021.791931. eCollection 2021.

Abstract

The relationship regarding non-coding genomes and cardiovascular disease (CVD) has been explored in the past decade. As one of the leading causes of death, there remains a lack of sensitive and specific genomic biomarkers in the diagnosis and prognosis of CVD. Piwi-interacting RNA (piRNA) is a group of small non-coding RNA (ncRNA) which associated with Piwi proteins. There is an emerging strong body of evidence in support of a role for ncRNAs, including piRNAs, in pathogenesis and prognosis of CVD. This article reviews the current evidence for piRNA-regulated mechanisms in CVD, which could lead to the development of new therapeutic strategies for prevention and treatment.

摘要

在过去十年中,人们对非编码基因组与心血管疾病(CVD)之间的关系进行了探索。作为主要死因之一,在CVD的诊断和预后方面,仍然缺乏敏感且特异的基因组生物标志物。Piwi相互作用RNA(piRNA)是一类与Piwi蛋白相关的小非编码RNA(ncRNA)。越来越多的有力证据支持包括piRNA在内的ncRNA在CVD发病机制和预后中发挥作用。本文综述了目前关于piRNA在CVD中调节机制的证据,这可能会促成预防和治疗CVD的新治疗策略的开发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/343c/11285661/e2dde21c83a3/fmmed-01-791931-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验